Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 147,139 | 70,445 | 239,240 | 666,655 | 88,311 |
| Cost of Goods | 22,104 | 21,496 | 15,325 | 14,115 | 36,669 |
| Gross Profit | 125,035 | 48,949 | 223,915 | 652,540 | 51,642 |
| Operating Expenses | 110,909 | 227,463 | 123,170 | 137,142 | 183,391 |
| Operating Income | 14,230 | -178,018 | 101,070 | 515,513 | -131,080 |
| Interest Expense | 5,824 | 5,482 | 5,518 | 5,723 | 7,585 |
| Other Income | 9,497 | -19,536 | 11,902 | 10,056 | 65,084 |
| Pre-tax Income | 17,903 | -203,036 | 107,454 | 519,846 | -73,581 |
| Income Tax | 376 | -657 | 946 | 1,200 | 7,449 |
| Net Income Continuous | 17,527 | -202,379 | 106,508 | 518,646 | -81,030 |
| Net Income | $17,527 | $-202,379 | $106,508 | $518,646 | $-81,030 |
| EPS Basic Total Ops | 0.09 | -1.25 | 0.66 | 3.22 | -0.51 |
| EPS Basic Continuous Ops | 0.09 | -1.25 | 0.66 | 3.22 | -0.51 |
| EPS Diluted Total Ops | 0.28 | -1.25 | 0.62 | 2.93 | -0.41 |
| EPS Diluted Continuous Ops | 0.27 | -1.25 | 0.60 | 2.92 | -0.40 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.62 | 0.62 | 2.93 | -0.51 |
| EBITDA(a) | $19,355 | $-171,433 | $108,633 | $523,853 | $-118,563 |